France· FR:68343525
KISQALI 200 mg, comprimé pelliculé
A medicinal product containing succinate de ribociclib, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SUCCINATE DE RIBOCICLIB
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 6
6 priced- cip133400930109335plaquette(s) polychlortrifluoroéthylène PVC de 21 comprimé(s)EUR 852.13
- cip133400930109342plaquette(s) polychlortrifluoroéthylène PVC de 42 comprimé(s)EUR 1.67
- cip133400930109359plaquette(s) polychlortrifluoroéthylène PVC de 63 comprimé(s)EUR 2.47
- cip133400930323434plaquette(s) polyamide aluminium PVC de 21 comprimé(s)EUR 851.48
- cip133400930323441plaquette(s) polyamide aluminium PVC de 42 comprimé(s)EUR 1.67
- cip133400930323458plaquette(s) polyamide aluminium PVC de 63 comprimé(s)EUR 2.47
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Succinate de ribociclib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKISQALINovartis Europharm Limited, Dublin
- United StatesKISQALINovartis Pharmaceuticals Corporation
- SpainKISQALI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- BelgiumKisqali 200 mgNovartis Europharm
- NetherlandsKisqali 200 mg filmomhulde tablettenNovartis Europharm Limited
- NorwayKisqaliNovartis Europharm Limited (1)
- PolandKisqaliNovartis Europharm Limited
- SwedenKisqali 200 mg Filmdragerad tablettNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kisqali
- Liechtenstein · Kisqali
- Norway · Kisqali
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac73a88a-e5a3-4549-bb3f-54cb378d6489 GET /v1/drugs/ac73a88a-e5a3-4549-bb3f-54cb378d6489?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68343525",
"date_amm": "2017-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1221",
"substance": "SUCCINATE DE RIBOCICLIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about succinate de ribociclib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.